Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

IICT develops synthetic process for Favipiravir, transfers to Cipla

expresspharmaMay 05, 2020

Tag: IICT , cipla , COVID-19 , favipiravir

PharmaSources Customer Service